A. Farnsworth

Improved tumor targeting with chemically cross-linked recombinant antibody fragments.

R. Owens, A. Lawson, R. Pedley, 1994, Cancer research.

Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.

R. Pedley, B. Boyce, J. Boden, 1994, British Journal of Cancer.

Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer.

S. Chan, M. Sopwith, R. Coleman, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

R. Owens, A. Lawson, R. Owens, 1995, British Journal of Cancer.

The influence of free DTPA on the dose distribution of yttrium-90 radiolabelled antibodies

A. Vaughan, A. Farnsworth, 1989 .

University of Southern Denmark Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma

Clemens, Donk, T. Plesner, 2021 .

Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)

T. Plesner, H. Nahi, A. Oriol, 2020, Haematologica.

Matrix-assisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator, and conjugated drug content.

M. Karas, M. Siegel, B. Smith, 1991, Analytical chemistry.

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

J. Humm, L. Old, S. Welt, 1996, British Journal of Cancer.

Preliminary results of a phase Ib trial of savolitinib combined with gefitinib in EGFR-mutant lung cancer.

Yi-long Wu, Jin-Ji Yang, Amir Handzel, 2016 .